112 related articles for article (PubMed ID: 1356905)
1. Expression of p170 protein in multiple myeloma: a clinical study.
Ucci G; Petrini M; Riccardi A; Invernizzi R; Carulli G; Luoni R; Giordano M; Danova M
Hematol Oncol; 1992; 10(3-4):213-20. PubMed ID: 1356905
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy.
Grogan TM; Spier CM; Salmon SE; Matzner M; Rybski J; Weinstein RS; Scheper RJ; Dalton WS
Blood; 1993 Jan; 81(2):490-5. PubMed ID: 8093668
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of multidrug-resistance-associated antigen (P-glycoprotein) and DNA ploidy in human colon cancer.
Danova M; Giordano M; Erba E; Palmeri S; Candiloro V; Riccardi A; Ucci G; Mazzini G; D'Incalci M; Ascari E
J Cancer Res Clin Oncol; 1992; 118(8):575-80. PubMed ID: 1355483
[TBL] [Abstract][Full Text] [Related]
4. [p170 in multiple myeloma and acute leukemia].
Riccardi A; Invernizzi R; Ucci G; Luoni R; Danova M; Giordano M; Zambelli ML; Rastaldi MP; Ascari E
Haematologica; 1991 Jun; 76 Suppl 3():177-80. PubMed ID: 1684345
[No Abstract] [Full Text] [Related]
5. A prognostic index for multiple myeloma.
Grignani G; Gobbi PG; Formisano R; Pieresca C; Ucci G; Brugnatelli S; Riccardi A; Ascari E
Br J Cancer; 1996 May; 73(9):1101-7. PubMed ID: 8624271
[TBL] [Abstract][Full Text] [Related]
6. Plasma cell P170 expression and response to treatment in multiple myeloma.
Patriarca F; Melli C; Damiani D; Michieli M; Michelutti A; Cavo M; Baccarani M
Haematologica; 1996; 81(3):232-7. PubMed ID: 8767528
[TBL] [Abstract][Full Text] [Related]
7. Treatment of multiple myeloma: a randomized study of three different regimens.
Tribalto M; Amadori S; Cantonetti M; Franchi A; Papa G; Pileri A; Boccadoro M; Dammacco F; Vacca A; Centurioni R
Leuk Res; 1985; 9(8):1043-9. PubMed ID: 3900591
[TBL] [Abstract][Full Text] [Related]
8. Rate of M-component changes and plasma cell labeling index in 25 patients with multiple myeloma treated with peptichemio.
Riccardi A; Montecucco C; Danova M; Ucci G; Merlini G; Ascari E
Cancer Treat Rep; 1985 Sep; 69(9):971-5. PubMed ID: 4028038
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia.
Michieli M; Damiani D; Geromin A; Michelutti A; Fanin R; Raspadori D; Russo D; Visani G; Dinota A; Pileri S
Eur J Haematol; 1992 Feb; 48(2):87-92. PubMed ID: 1347749
[TBL] [Abstract][Full Text] [Related]
10. DNA content of human myeloma cells.
Lewensohn R; Tribukait B; Hansson J
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):59-63. PubMed ID: 6682777
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1).
Liu B; Sun D; Xia W; Hung MC; Yu D
J Natl Cancer Inst; 1997 Oct; 89(20):1524-9. PubMed ID: 9337349
[TBL] [Abstract][Full Text] [Related]
12. Peptichemio in multiple myeloma. (Preliminary results).
Cavo M; Gobbi M; Tura S
Haematologica; 1981 Apr; 66(2):208-15. PubMed ID: 6791997
[No Abstract] [Full Text] [Related]
13. Alternating intravenous courses of melphalan and peptichemio in high-risk multiple myeloma (preliminary results).
Franchi F; Seminara P; Rossi Fanelli F
Anticancer Res; 1986; 6(2):297-8. PubMed ID: 3707066
[TBL] [Abstract][Full Text] [Related]
14. Prednisone pulse therapy for refractory myeloma.
Alexanian R; Yap BS; Bodey GP
Blood; 1983 Sep; 62(3):572-7. PubMed ID: 6882916
[TBL] [Abstract][Full Text] [Related]
15. Peptichemio, vincristine and prednisone versus melphalan and prednisone as induction therapy in multiple myeloma.
Riccardi A; Merlini G; Montecucco C; Danova M; Ucci G; Cassano E; Ascari E
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):787-91. PubMed ID: 3770037
[TBL] [Abstract][Full Text] [Related]
16. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas.
Pileri SA; Sabattini E; Falini B; Tazzari PL; Gherlinzoni F; Michieli MG; Damiani D; Zucchini L; Gobbi M; Tsuruo T
Histopathology; 1991 Aug; 19(2):131-40. PubMed ID: 1684559
[TBL] [Abstract][Full Text] [Related]
18. Remission maintenance therapy for multiple myeloma.
Arch Intern Med; 1975 Jan; 135(1):147-52. PubMed ID: 1111463
[TBL] [Abstract][Full Text] [Related]
19. Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis?
Mongkonsritragoon W; Kimlinger T; Ahmann G; Greipp PR
Leuk Lymphoma; 1998 May; 29(5-6):577-84. PubMed ID: 9643571
[TBL] [Abstract][Full Text] [Related]
20. Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study.
Danova M; Riccardi A; Ucci G; Luoni R; Giordano M; Mazzini G
Br J Cancer; 1990 Nov; 62(5):781-5. PubMed ID: 2245170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
